Given that HGPS patients die prematurely from cardiovascular disease, a deeper understanding of the mechanisms through which progerin expression leads to premature cardiovascular pathology is essential to provide therapies for HGPS patients. The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.